3,798
Views
15
CrossRef citations to date
0
Altmetric
Research Article

Pharmacological effects of Chatuphalatika in hyperuricemia of gout

ORCID Icon, , , , , & show all
Pages 76-85 | Received 01 Jun 2017, Accepted 21 Dec 2017, Published online: 03 Jan 2018

References

  • Attard E. 2013. A rapid microtitre plate Folin-Ciocalteu method for the assessment of polyphenols. Cent Eur J Biol. 8:48–53.
  • Billiet L, Doaty S, Katz JD, Velasquez MT. 2014. Review of hyperuricemia as new marker for metabolic syndrome. ISRN Rheumatol. 2014:852954.
  • Biswas M, Bhattacharya S, Ghosh AK, Kumar RB, Bera S, Gupta M, Haldar PK. 2012. Antitumour activity of Terminalia arjuna leaf against Ehrlich ascites carcinoma in mice. Nat Prod Res. 26:1141–1144.
  • Biswas M, Kar B, Bhattacharya S, Kumar RB, Ghosh AK, Haldar PK. 2011. Antihyperglycemic activity and antioxidant role of Terminalia arjuna leaf in streptozotocin-induced diabetic rats. Pharm Biol. 49:335–340.
  • Carro MD, Falkenstein E, Radke WJ, Klandorf H. 2010. Effects of allopurinol on uric acid concentrations, xanthine oxidoreductase activity and antioxidative stress in broiler chickens. Comp Biochem Physiol C Toxicol Pharmacol. 151:12–17.
  • Charoenchai L, Pathompak P, Madaka F, Settharaksa S, Saingam W. 2016. HPLC-MS profiles and quantitative analysis of triphala formulation. BHST. 14:57–67.
  • Chavalittumrong P, Attawish A, Rugsamon P, Chuntapet R. 1996. Subacute toxicity of traditional medicinal triphala. Bull Dept Med Sci. 38:169–191.
  • El-Boghdady NA. 2011. Protective effect of ellagic acid and pumpkin seed oil against methotrexate-induced small intestine damage in rats. Indian J Biochem Biophys. 48:380–387.
  • Guimarães MR, Leite FRM, Spolidorio LC, Kirkwood KL, Rossa C. 2013. Curcumin abrogates LPS-induced proinflammatory cytokines in RAW 264.7 macrophages. Evidence for novel mechanisms involving SOCS-1, -3 and p38 MAPK. Arch Oral Biol. 58:1309–1317.
  • Hou CW, Lee YC, Hung HF, Fu HW, Jeng KC. 2012. Longan seed extract reduces hyperuricemia via modulating urate transporters and suppressing xanthine oxidase activity. Am J Chin Med. 40:979–991.
  • Hozawa A, Folsom AR, Ibrahim H, Nieto FJ, Rosamond WD, Shahar E. 2006. Serum uric acid and risk of ischemic stroke: the ARIC Study. Atherosclerosis. 187:401–407.
  • Kalaiselvan S, Rasool M. 2015. Triphala exhibits anti-arthritic effect by ameliorating bone and cartilage degradation in adjuvant-induced arthritic rats. Immunol Invest. 44:411–426.
  • Kelkar A, Kuo A, Frishman WH. 2011. Allopurinol as a cardiovascular drug. Cardiol Rev. 19:265–271.
  • Kong LD, Cai Y, Huang WW, Cheng CH, Tan RX. 2000. Inhibition of xanthine oxidase by some Chinese medicinal plants used to treat gout. J Ethnopharmacol. 73:199–207.
  • Li M, Hu X, Fan Y, Li K, Zhang X, Hou W, Tang Z. 2016. Hyperuricemia and the risk for coronary heart disease morbidity and mortality a systematic review and dose-response meta-analysis. Sci Rep. 6:19520.
  • Ling X, Bochu W. 2014. A review of phytotherapy of gout: perspective of new pharmacological treatments. Pharmazie. 69:243–256.
  • Mancia G, Grassi G, Borghi C. 2015. Hyperuricemia, urate deposition and the association with hypertension. Curr Med Res Opin. 31:15–19.
  • Mandal S, Patra A, Samanta A, Roy S, Mandal A, Mahapatra TD, Pradhan S, Das K, Nandi DK. 2013. Analysis of phytochemical profile of Terminalia arjuna bark extract with antioxidative and antimicrobial properties. Asian Pac J Trop Biomed. 3:960–966.
  • Masuoka N, Nihei K, Kubo I. 2006. Xanthine oxidase inhibitory activity of alkyl gallates. Mol Nutr Food Res. 50:725–731.
  • Nair AB, Jacob SA. 2016. A simple practice guide for dose conversion between animals and human. J Basic Clin Pharm. 7:27–31.
  • Naik GH, Priyadarsini KI, Mohan H. 2006. Free radical scavenging reactions and phytochemical analysis of Triphala, an ayurvedic formulation. Curr Sci. 90:1100–1105.
  • Organization for Economic Cooperation and Development (OECD). 2001. Guideline for testing of chemicals. Revised Draft Guideline 423. Document on acute oral toxicity and acute toxicity class method. Paris. http://www.oecd.org.
  • Sabina EP, Rasool M. 2008. An in vivo and in vitro potential of Indian ayurvedic herbal formulation Triphala on experimental gouty arthritis in mice. Vascul Pharmacol. 48:14–20.
  • Saralamp P, Soonthornchareonnon N, Anatachok N. 2011. Handbook of medicinal herbs in national essential drug list. Bangkok (Thailand): Concept Medicus.
  • Sato VH, Sungthong B, Nuamnaichati N, Rinthong PO, Mangmool S, Sato H. 2017. In vivo and in vitro evidence for the antihyperuricemic, anti-inflammatory and antioxidant effects of a traditional Ayurvedic medicine, triphala. Nat Prod Com. 12:1635–1638.
  • Shinde SL, Junne SB, Wadje SS, Baig MM. 2009. The diversity of antibacterial compounds of Terminalia species (Combretaceae). Pak J Biol Sci. 12:1483–1486.
  • Smith RD, Essenburg AD, Kaplan HR. 1979. The oxonate pretreated rat as a model for evaluating hyperuricemic effects of antihypertensive drugs. Clin Exp Hypertens. 1:487–504.
  • So A, Thorens B. 2010. Uric acid transport and disease. J Clin Invest. 120:1791–1799.
  • Stockert JC, Blázquez-Castro A, Cañete M, Horobin RW, Villanueva Á. 2012. MTT assay for cell viability: intracellular localization of the formazan product is in lipid droplets. Acta Histochemica. 114:785–796.
  • Thaipong K, Boonprakob U, Crosby K, Cisneros-Zevallos L, Hawkins Byrne D. 2006. Comparison of ABTS, DPPH, FRAP, and ORAC assays for estimating antioxidant activity from guava fruit extracts. J Food Comp Anal. 19:669–675.